How do we close the gap between the knowledge of today and the possibilities of tomorrow?
We partner with leading research institutions to help them
provide best-in-class care, advance clinical research, and run clinical trials.
Superior Clinical Care Through Better Insights
Molecular Tumor Boards
These virtual meetings feature discussions about select test reports, the genomic alterations identified, and related implications. Foundation Medicine’s scientific and medical experts and care teams from cancer centers across the country work collaboratively to address the most complex cases.
Better Data, Better Insights
Foundation Medicine’s FoundationCORE™ knowledgebase contains more than 120,000 genomic profiles and over 150 cancer subtypes. Access FoundationCORE through FoundationINSIGHTSTM, our innovative data platform for genomic and clinico-genomic research.
Our industry-leading medical and scientific teams are here to support your goals — leveraging in-depth molecular insights, experience, and a breadth of offerings to help you bring new therapies to cancer patients.
Podium Presentations at Scientific Conferences
Poster Presentations at Scientific Conferences
Publications in Peer-reviewed Journals
We can help you ...
Profile large patient
de novo biomarker discovery or identification of patients
for clinical trials
Provide insight into trends involving complex
biomarkers such as
microsatellite instability (MSI) and tumor mutational burden
Connect your experts with our experts via our
extensive network of scientists, institutions, and biopharma companies.
Data exchange is an important component to making the benefits of precision medicine accessible to everyone. We believe providing access to our molecular information platform and knowledgebase can accelerate new cancer treatments and discoveries, thus improving access to appropriate therapies for patients in the future.
Better, More Efficient Clinical Trials
Foundation Medicine sits at a nexus of medicine and
pharmaceutical research. We are adding hundreds
of patient genomic profiles per week to our FoundationCORE database (notably
enriched for patients with rare findings) while simultaneously working with our
biopharma partners to cull the most up-to-date clinical trial information. Together, we help institutions run trials
faster and smarter, providing better access to treatment options for patients.
Just-In-Time Trial Networks
Too often, patients with rare findings are seen in settings where trials are not routinely considered. And even if they are, trial sites are frequently too far for matched patients to reach.
Our just-in-time network allows trial site activation –
with IRB approval – to be possible in less than a week.
Once profiled, patients' genomic data become available in our custom reports. Test results are provided in a user-friendly interpretive report that highlights the genomic alterations present in the patient’s cancer and provides information about targeted therapies and clinical trials to inform treatment decisions.